Literature DB >> 24650454

MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4.

Jing Zhang1, Yang Yang2, Yang Liu3, Yuxia Fan3, Zheng Liu3, Xiaoming Wang3, Qingling Yuan3, Yixing Yin3, Jie Yu3, Meiju Zhu3, Jian Zheng3, Xiubo Lu4.   

Abstract

BACKGROUND: Our recent study has found that microRNA-21 (miRNA-21) was significantly upregulated in papillary thyroid carcinoma (PTC) tissues compared with nontumor tissues by using miRNA microarray chip. However, the function of miRNA-21 is unknown in PTC. The aim of this study was to investigate the roles of miRNA-21 in PTC and the mechanism of gene regulation by it.
METHODS: We transfected PTC cell line (TPC-1) with pEZX-eGFP-miRNA-21 plasmid to determine the biological functions of miRNA-21. Western blot assay was applied to investigate the correlation between miRNA-21 and programmed cell death 4 (PDCD4) expression in TPC-1 cell line.
RESULTS: Overexpression of miRNA-21 could significantly enhance proliferation and invasion and inhibit the apoptosis of TPC-1 cells. In addition, miRNA-21 and PDCD4 expression showed a significantly negative correlation in TPC-1 cells.
CONCLUSIONS: These data suggest that miRNA-21 may play an oncogenic role by directly targeting PDCD4 in the cellular processes of PTC. In addition, the findings in our present study also may represent new clues for the diagnostic and therapeutic strategies in the treatment of PTC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MicroRNA-21; Papillary thyroid carcinoma; Programmed cell death 4; TPC-1

Mesh:

Substances:

Year:  2014        PMID: 24650454     DOI: 10.1016/j.jss.2014.02.012

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

1.  In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.

Authors:  Zhenying Guo; Heather Hardin; Celina Montemayor-Garcia; Sofia Asioli; Alberto Righi; Francesca Maletta; Anna Sapino; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

2.  Cancer stem cells as a potential therapeutic target in thyroid carcinoma.

Authors:  Luisa Vicari; Cristina Colarossi; Dario Giuffrida; Ruggero De Maria; Lorenzo Memeo
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

3.  Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma.

Authors:  Xiaojun Chen; Wenjun Wu; Xiong Chen; Xiaohua Gong
Journal:  Tumour Biol       Date:  2015-12-04

Review 4.  Non-Coding RNAs in Thyroid Cancer.

Authors:  Ranran Zhang; Heather Hardin; Jidong Chen; Zhenying Guo; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

5.  MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.

Authors:  Ebru Esin Yoruker; Duygu Terzioglu; Serkan Teksoz; Fatma Ezel Uslu; Ugur Gezer; Nejat Dalay
Journal:  J Cancer       Date:  2016-04-26       Impact factor: 4.207

6.  Identification of potential therapeutic targets for papillary thyroid carcinoma by bioinformatics analysis.

Authors:  Ming Zhao; Ke-Jing Wang; Zhuo Tan; Chuan-Ming Zheng; Zhong Liang; Jian-Qiang Zhao
Journal:  Oncol Lett       Date:  2015-10-26       Impact factor: 2.967

Review 7.  miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers.

Authors:  Manuel Saiselet; Jaime M Pita; Alice Augenlicht; Geneviève Dom; Maxime Tarabichi; Danai Fimereli; Jacques E Dumont; Vincent Detours; Carine Maenhaut
Journal:  Oncotarget       Date:  2016-08-09

8.  Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.

Authors:  Raagini Suresh; Seema Sethi; Shadan Ali; Tamar Giorgadze; Fazlul H Sarkar
Journal:  J Cancer Sci Ther       Date:  2015-05

9.  MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.

Authors:  Wangwang Qiu; Zhili Yang; Youben Fan; Qi Zheng
Journal:  Oncotarget       Date:  2016-06-28

10.  Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.

Authors:  Weixin Liang; Yongqiang Lai; Mingzhang Zhu; Shangshu Huang; Weizhao Feng; Xiaoyu Gu
Journal:  Med Sci Monit       Date:  2016-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.